Frontiers in Cardiovascular Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-11-01 ms9000000439591833

偏重的研究方向：心血管影像诊断
经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。

191 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-01-03 黄伟民

审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0
偏重的研究方向：心脏再生;心外科
经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!

240 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-11-20 小凯丫丫

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。

178 0

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-11-13 ms2000001425378496

有没有可能今年被预警啊，太担心了

219 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-08-15 亦团团

审稿速度:2.0
偏重的研究方向：心血管
经验分享：各位接收的朋友 final validation得需要多久才有回复啊

520 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-11-01 ms2000001795531851

如果用公开的医学数据库，会要求提供原始数据吗

475 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-07-05 ms2000000006812695

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：冠心病
经验分享：一篇横断面研究，投的一波三折。
21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。
大修后重投，时间线如下：
Received date: 01 May 2022
Editorial assignment start date: 06 May 2022
Independent review start date: 06 May 2022
Interactive review activated date: 27 May 2022
Review finalized date: 02 Jul 2022
Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了

540 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-10-12 ms7000000888761661

审稿速度:6.0 | 投稿命中率:95.0
偏重的研究方向：子痫前期
经验分享：Received date: 05 May 2022
Editorial assignment start date: 09 May 2022
Independent review start date: 22 May 2022
Interactive review activated date: 28 Jun 2022
Review finalized date: 11 Oct 2022
Final validation date: 12 Oct 2022

928 0

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-10-13 ms3000002000721412

偏重的研究方向：Meta分析
经验分享：我之前投一个杂志，投稿3，接受10

173 0

[GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101659, encodeId=ecfb2101659bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：编辑对我的文章比较感兴趣，虽然第二位审稿人拒绝了，但是编辑立马找了第三位，不过和第一位审稿人大战了半个月（7个来回），你来我往的解释及完善，最后同意接收发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/b23ef8c45e894c42aec2ec8d68eef51b/9062fdc9039048e89336083882555704.jpg, createdBy=dd262453814, createdName=小凯丫丫, createdTime=Sun Nov 20 20:45:35 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100251, encodeId=9bc221002512c, content=有没有可能今年被预警啊，太担心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96e8116016, createdName=ms2000001425378496, createdTime=Sun Nov 13 14:12:54 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238880, encodeId=566f1238880f7, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：各位接收的朋友 final validation得需要多久才有回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/11a012eb14f548529b0040b50f0e1d04/fd2e863d4fe34675a9d7b92b40a79b65.jpg, createdBy=0c895126331, createdName=亦团团, createdTime=Mon Aug 15 21:15:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097941, encodeId=bcd7209e94171, content=如果用公开的医学数据库，会要求提供原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66d8408907, createdName=ms2000001795531851, createdTime=Tue Nov 01 21:43:23 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230647, encodeId=3845123064eb4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：冠心病 经验分享：一篇横断面研究，投的一波三折。 21年12月第一次投，送了6个Reviewer（编辑发邮件让推荐至少5个，可能和这个有关），一个半月意见全回，3个endorsed，3个rejected，Reviewer comments都关了，编辑要求1周修稿，大年初三修回，不到半小时副主编拒稿，理由是The editor and three reviewers have raised major criticisms which limit the priority of this paper。 大修后重投，时间线如下： Received date: 01 May 2022 Editorial assignment start date: 06 May 2022 Independent review start date: 06 May 2022 Interactive review activated date: 27 May 2022 Review finalized date: 02 Jul 2022 Final validation date: 04 Jul 2022，同日接收，从投稿到接收2个月，速度真的很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5628509, createdName=ms2000000006812695, createdTime=Tue Jul 05 10:56:06 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093517, encodeId=c39d209351e5a, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：子痫前期 经验分享：Received date: 05 May 2022 Editorial assignment start date: 09 May 2022 Independent review start date: 22 May 2022 Interactive review activated date: 28 Jun 2022 Review finalized date: 11 Oct 2022 Final validation date: 12 Oct 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=928, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Wed Oct 12 23:54:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093539, encodeId=7fed2093539b9, content=偏重的研究方向：Meta分析 经验分享：我之前投一个杂志，投稿3，接受10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38495446872, createdName=ms3000002000721412, createdTime=Thu Oct 13 08:49:59 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231014, encodeId=9d031231014d2, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：生信 经验分享：5.10投稿 7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Wed Jul 06 21:28:20 CST 2022, time=2022-07-06, status=1, ipAttribution=)]

2022-07-06 361152897

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：生信
经验分享：5.10投稿
7.5接受

409 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务